MedPath
HSA Product

DHASEDYL DM SYRUP

Product approved by Health Sciences Authority (SG)

Basic Information

DHASEDYL DM SYRUP

SYRUP

Regulatory Information

SIN08748P

June 25, 1996

Pharmacy Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XR06AD52

Company Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Active Ingredients

DEXTROMETHORPHAN HBr

Strength: 10 mg/5 ml

EPHEDRINE HCl

Strength: 6 mg/5 ml

PROMETHAZINE HCl

Strength: 3.6 mg/5 ml

Detailed Information

Contraindications

Under **PRECAUTIONS** Do not take this medicine if you are allergic to any of the ingredients (promethazine, dextromethorphan, ephedrine) in this product. Do not take this medicine during pregnancy or breast feeding, before consulting your doctor or pharmacist. Do not take this medicine after the expiry date stated on the label. Do not take this medicine if you have liver disease, bronchial asthma, or receiving MAO (monoamine oxidase) inhibitors for conditions such as depression or Parkinson's disease.

Indication Information

**WHAT IS DHASEDYL DM SYRUP USED FOR?** Dhasedyl DM syrup contains: Dextromethorphan: an opioid derivative and cough suppressant for relieving non-productive cough. Promethazine: a sedating phenothiazine derivative antihistamine, which relieves symptoms of allergic condition and rhinitis. Ephedrine: has sympathomimetic effect which is used for symptomatic relief of nasal congestion. This formulation is used for temporary or short term (7 days) relief of symptoms of cough and cold. If symptoms persist, consult the physician. Dosage should not be increased if cough fails to respond.

© Copyright 2025. All Rights Reserved by MedPath